Volume | 795 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 9,01 | Bas Haut |
|||||
Minimum Bas | 8,91 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Talis Biomedical Corporation | TLIS | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
9,01 | 8,91 | 9,01 | 8,91 | 8,995 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
27 | 795 | US$ 8,91 | US$ 7 083 | - | 4,35 - 9,60 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:00:00 | 3 | US$ 9,02 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
16,23M | 1,82M | - | 2,13M | -62,01M | -34,05 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Talis Biomedical
Date | Heure | Source | Titre |
---|---|---|---|
08/5/2024 | 14:04 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
26/1/2024 | 22:33 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2023 | 14:00 | GlobeNewswire Inc. | Talis Biomedical Announces Exploration of Strategic.. |
01/9/2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
10/8/2023 | 23:01 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
10/8/2023 | 22:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/8/2023 | 22:11 | Edgar (US Regulatory) | Form 8-K - Current report |
10/8/2023 | 22:05 | GlobeNewswire Inc. | Talis Biomedical Announces Second Quarter 2023 Financial.. |
03/8/2023 | 14:00 | GlobeNewswire Inc. | Talis Biomedical to Report Second Quarter 2023 Financial.. |
02/8/2023 | 14:18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
02/8/2023 | 14:17 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
02/8/2023 | 14:15 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Talis Biomedical
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Talis Biomedical Corporation
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 9,10 | 9,25 | 8,88 | 9,05 | 4 115 | -0,19 | -2,09% |
1 mois | 9,03 | 9,5299 | 8,68 | 9,01 | 5 758 | -0,12 | -1,33% |
3 mois | 9,23 | 9,60 | 7,5001 | 8,84 | 7 239 | -0,32 | -3,47% |
6 mois | 8,25 | 9,60 | 7,01 | 8,42 | 8 340 | 0,66 | 8,00% |
1 an | 7,467 | 9,60 | 4,35 | 7,41 | 20 223 | 1,44 | 19,33% |
3 ans | 180,00 | 193,20 | 4,35 | 58,05 | 127 182 | -171,09 | -95,05% |
5 ans | 435,00 | 507,90 | 4,35 | 89,65 | 139 982 | -426,09 | -97,95% |